Daniel Pfeffer, Director of Oligonucleotide Production at Bachem shares why CDMO innovation is key to advancing next-generation oligonucleotide therapies.
Bachem
Optimised oligo delivery to meet rising demand
Daniel Pfeffer, Director of Oligonucleotide Production at Bachem shares why CDMO innovation is key to advancing next-generation oligonucleotide therapies.
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.